Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
The demand of Calcium Channel Blocker is concentrated in developed areas like USA and Europe. In 2016, the consumption of Calcium Channel Blocker in USA was 26.78%, ahead of other regions. Other regions also enjoy the major market share in global region.
In the future, the Calcium Channel Blocker will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the monopoly phenomenon will be weaken. The installed rate in the commercial vehicle will increase.
According to this study, over the next five years the Calcium Channel Blocker market will register a 1.5% CAGR in terms of revenue, the global market size will reach USD 78 million by 2024, from USD 72 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Calcium Channel Blocker business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Calcium Channel Blocker market by product type, application, key manufacturers and key regions and countries.
This study considers the Calcium Channel Blocker value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Dihydropyridine
Diltiazem
Verapamil
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Calcium Channel Blocker consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Calcium Channel Blocker market by identifying its various subsegments.
Focuses on the key global Calcium Channel Blocker manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Calcium Channel Blocker with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Calcium Channel Blocker submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
